Search research articles
Contact Us
Filters
Showing results (121-130 of 289) with videos related to
Page
of 29
Sort By:
Tumori
|
October 28, 2009
Pitfalls in the diagnosis of neuroendocrine tumors: atypical clinical and radiological findings as cause of medical mistakes
Emilio Bajetta, Laura Catena, Monika Ducceschi, et al.
Tumori
|
October 7, 2024
Hot topics in genitourinary cancers: A multidisciplinary discussion on state-of-the-art and latest developments among international experts and patient advocacy
Alessandro Rametta, Paolo Ambrosini, Chiara Cavalli, et al.
Clinical Genitourinary Cancer
|
January 31, 2024
Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or Pazopanib
Martina Catalano, Ugo De Giorgi, Davide Bimbatti, et al.
Oncology
|
September 28, 2021
Safety and Efficacy of Tivozanib in First-Line mRCC: A Multicenter Compassionate-Use Study (Meet-Uro 16)
Umberto Basso, Giuseppe Procopio, Giuseppe Fornarini, et al.
Expert Review of Anticancer Therapy
|
August 8, 2020
The emerging role of PARP inhibitors in prostate cancer
Marco Stellato, Valentina Guadalupi, Pierangela Sepe, et al.
Biomedicines
|
October 27, 2022
Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma
Martina Catalano, Ugo De Giorgi, Marco Maruzzo, et al.
American Journal of Clinical Oncology
|
September 5, 2020
Prospective Translational Study Investigating Molecular PrEdictors of Resistance to First-Line PazopanIb in Metastatic reNal CEll Carcinoma (PIPELINE Study)
Pierangela Sepe, Antonia Martinetti, Alessia Mennitto, et al.
Tumori
|
November 6, 2020
Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma
Raffaele Ratta, Elena Verzoni, Alessia Mennitto, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 17, 2020
Patient associations and clinical oncology research: how much does a patient's voice really matter?
Veronica Franchina, Celeste Cagnazzo, Alessandro Di Costanzo, et al.
European Urology Oncology
|
July 24, 2019
Metastatic Renal Cell Carcinoma Rapidly Progressive to Sunitinib: What to Do Next?
Melissa Bersanelli, Roberto Iacovelli, Sebastiano Buti, et al.
Page
of 29
Search research articles
Search
Showing results (121-130 of 289) with videos related to
Sort By:
Page
of 29
Tumori
|
October 28, 2009
Pitfalls in the diagnosis of neuroendocrine tumors: atypical clinical and radiological findings as cause of medical mistakes
Emilio Bajetta, Laura Catena, Monika Ducceschi, et al.
Tumori
|
October 7, 2024
Hot topics in genitourinary cancers: A multidisciplinary discussion on state-of-the-art and latest developments among international experts and patient advocacy
Alessandro Rametta, Paolo Ambrosini, Chiara Cavalli, et al.
Clinical Genitourinary Cancer
|
January 31, 2024
Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or Pazopanib
Martina Catalano, Ugo De Giorgi, Davide Bimbatti, et al.
Oncology
|
September 28, 2021
Safety and Efficacy of Tivozanib in First-Line mRCC: A Multicenter Compassionate-Use Study (Meet-Uro 16)
Umberto Basso, Giuseppe Procopio, Giuseppe Fornarini, et al.
Expert Review of Anticancer Therapy
|
August 8, 2020
The emerging role of PARP inhibitors in prostate cancer
Marco Stellato, Valentina Guadalupi, Pierangela Sepe, et al.
Biomedicines
|
October 27, 2022
Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma
Martina Catalano, Ugo De Giorgi, Marco Maruzzo, et al.
American Journal of Clinical Oncology
|
September 5, 2020
Prospective Translational Study Investigating Molecular PrEdictors of Resistance to First-Line PazopanIb in Metastatic reNal CEll Carcinoma (PIPELINE Study)
Pierangela Sepe, Antonia Martinetti, Alessia Mennitto, et al.
Tumori
|
November 6, 2020
Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma
Raffaele Ratta, Elena Verzoni, Alessia Mennitto, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 17, 2020
Patient associations and clinical oncology research: how much does a patient's voice really matter?
Veronica Franchina, Celeste Cagnazzo, Alessandro Di Costanzo, et al.
European Urology Oncology
|
July 24, 2019
Metastatic Renal Cell Carcinoma Rapidly Progressive to Sunitinib: What to Do Next?
Melissa Bersanelli, Roberto Iacovelli, Sebastiano Buti, et al.
Page
of 29